Company News
Camurus Shares Fall 7% After FDA Rejection
Shares of Camurus (ST:CAMX) dropped 7% on Thursday after the FDA rejected its Oclaiz application for acromegaly.
FDA cited need for a third‑party facility reinspection and a minor labeling change, not
